Edition:
United States

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

7.95USD
1:28pm EDT
Change (% chg)

$-0.05 (-0.62%)
Prev Close
$8.00
Open
$7.90
Day's High
$8.00
Day's Low
$7.85
Volume
16,566
Avg. Vol
60,643
52-wk High
$8.80
52-wk Low
$2.45

Chart for

About

Vital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy... (more)

Overall

Beta: 5.35
Market Cap(Mil.): $249.02
Shares Outstanding(Mil.): 42.21
Dividend: --
Yield (%): --

Financials

  VTL.OQ Industry Sector
P/E (TTM): -- 85.36 32.76
EPS (TTM): -1.37 -- --
ROI: -63.60 2.21 14.61
ROE: -63.63 3.85 16.34

BRIEF-Vital Therapies Q1 Loss Per Share $0.34

* VITAL THERAPIES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Vital Therapies Announces VTL-308 Reaches Enrollment Target Of 150 Subjects

* VITAL THERAPIES ANNOUNCES VTL-308 REACHES ENROLLMENT TARGET OF 150 SUBJECTS

Mar 22 2018

BRIEF-Vital Therapies Announces Q4 Loss Per Share $0.35

* VITAL THERAPIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 13 2018

Earnings vs. Estimates